Racial/ethnic disparities are seen in COVID-19 vaccination coverage among children and adolescents, according to research published in the Jan. 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and ...
Jan 6, 2023
0
2
Mpox cases reported in cisgender women represent 2.7 percent of all reported cases, according to research published in the Jan. 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly ...
Jan 6, 2023
0
5
Individuals with mpox infection ≥14 days after receipt of one JYNNEOS vaccine dose have less hospitalization, fever, headache, malaise, myalgia, and chills compared with unvaccinated individuals, according to research published ...
Dec 29, 2022
0
7
In a report published in the Dec. 16 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, data are presented on coinfection with influenza and severe acute respiratory syndrome ...
Dec 20, 2022
0
9
A new surveillance case definition for multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been developed, according to research ...
Dec 19, 2022
0
6
One of the first real-world data studies comparing the new bivalent mRNA COVID-19 booster vaccines with the original monovalent vaccines reports the bivalent conveyed greater short-term protection against symptomatic COVID-19 ...
Dec 19, 2022
0
36
Kids who get the flu and COVID-19 together may be in for a serious, even deadly, bout of illness, U.S. health officials said Friday.
Dec 16, 2022
0
3
About 10 percent of deaths among ever-employed persons aged 15 years and older were associated with chronic obstructive pulmonary disease (COPD) in 2020, according to research published in the Dec. 9 issue of the U.S. Centers ...
Dec 9, 2022
0
3
The JYNNEOS vaccine, which is recommended for persons exposed to or at high risk for exposure to mpox virus, seems safe, with the most common adverse health events reported as nonserious, according to research published ...
Dec 9, 2022
0
2
Among men aged 18 to 49 years who are eligible for the JYNNEOS vaccine, mpox incidence is considerably higher among unvaccinated persons versus those who received one or two vaccine doses, according to research published ...
Dec 9, 2022
0
3
